60th Annual Meeting

October 19 - 27, 2013

Vinod Kumar, MD

Novartis Pharmaceutical Corporation
Novartis Pharmaceuticals Corporation,
East Hanover, NJ, USA
East Hanover, NJ
USA

Papers:
16.1 Methylphenidate Hydrochloride Modified Release for Adults with ADHD: A 40-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy, and Safety Study 16.2 Methylphenidate Hydrochloride Modified Release in Adults with ADHD: Self-Rated, Observer-Rated, and Physician-Rated Assessments Show Consistently Significant Improvement Compared to Placebo